サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1467626

組織診断市場レポート：製品タイプ、技術、疾患、エンドユーザー、地域別、2024～2032年

Tissue Diagnostics Market Report by Product Type, Technology, Disease, End-User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 135 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
組織診断市場レポート：製品タイプ、技術、疾患、エンドユーザー、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の組織診断市場規模は2023年に55億米ドルに達しました。今後、IMARC Groupは、2024～2032年にかけて5.9%の成長率（CAGR）を示し、2032年までに94億米ドルに達すると予測しています。

組織診断には、疾患の生物学的背景を捉えることによる特定の組織サンプルの分析と試験が含まれます。がんや炎症性疾患のような特定の病状を検出するために使用され、悪性腫瘍の正確な種類と程度を明らかにすることで、潜在的な原因や治療法を特定するのに役立ちます。組織診断は非常に正確で安価であり、コア生検や開腹生検といった様々な手法で実施することができます。最近では、免疫組織化学（IHC）、in situハイブリダイゼーション（ISH）、デジタルパソロジー、特殊染色などの高度な技術もこれらの診断に用いられています。

出生率の低下と平均余命の伸びにより、高齢者人口の全体的な割合は現在世界中で着実に増加しています。高齢者は慢性疾患にかかりやすいため、頻繁な試験と診断が必要となります。これとは別に、食事パターンの変化、アルコール消費量の増加、身体活動の低下などが、いくつかの生活習慣病の発生率の上昇につながっています。これに加えて、あらゆる年齢層で様々な種類のがんの有病率が上昇していることも、こうした診断サービスに対する需要の急増につながっています。

本レポートで扱う主要質問

  • 世界の組織診断市場の規模は？
  • 2024～2032年における組織診断の世界市場成長率は？
  • 組織診断の世界市場を牽引する主要因は何か？
  • COVID-19が組織診断の世界市場に与えた影響は？
  • 組織診断の世界市場の製品タイプ別内訳は？
  • 組織診断の世界市場の技術別区分は？
  • 組織診断の世界市場の疾患別区分は？
  • 組織診断の世界市場のエンドユーザー別区分は？
  • 組織診断の世界市場における主要地域は？
  • 組織診断の世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の組織診断市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場内訳：製品タイプ別
  • 市場内訳：技術別
  • 市場内訳：疾患別
  • 市場内訳：エンドユーザー別
  • 市場内訳：地域別
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 医療機器
  • 消耗品

第7章 市場内訳：技術別

  • 免疫組織化学
  • in situハイブリダイゼーション
  • デジタルパソロジーとワークフロー管理
  • 特殊染色

第8章 市場内訳：疾患別

  • 乳がん
  • 胃がん
  • リンパ腫
  • 前立腺がん
  • 非小細胞肺がん
  • その他

第9章 市場内訳：エンドユーザー別

  • 病院
  • 調査研究所
  • 製薬会社
  • 調査受託機関
  • その他

第10章 市場内訳：地域別

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ地域
  • ラテンアメリカ

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

  • 価格指標
  • 価格構造
  • マージン分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Roche
    • Danaher
    • Thermo Fisher Scientific
    • Abbott
    • Agilent Technologies
    • Merck
    • Sakura Finetek Japan
    • Abcam
    • BD
    • Qiagen
    • Bio SB
    • Biogenex
    • Cell Signaling Technology
図表

List of Figures

  • Figure 1: Global: Tissue Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Tissue Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Tissue Diagnostics Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Tissue Diagnostics Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Tissue Diagnostics Market: Breakup by Disease (in %), 2023
  • Figure 6: Global: Tissue Diagnostics Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Tissue Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Tissue Diagnostics Industry: SWOT Analysis
  • Figure 9: Global: Tissue Diagnostics Industry: Value Chain Analysis
  • Figure 10: Global: Tissue Diagnostics Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Tissue Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 12: Global: Tissue Diagnostics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Tissue Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Tissue Diagnostics (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Tissue Diagnostics (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Tissue Diagnostics (Immunohistochemistry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Tissue Diagnostics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Tissue Diagnostics (In Situ Hybridization) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Tissue Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Tissue Diagnostics (Digital Pathology and Workflow Management) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Tissue Diagnostics (Digital Pathology and Workflow Management) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Tissue Diagnostics (Special Staining) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Tissue Diagnostics (Special Staining) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Tissue Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Tissue Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Tissue Diagnostics (Gastric Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Tissue Diagnostics (Gastric Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Tissue Diagnostics (Lymphoma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Tissue Diagnostics (Lymphoma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Tissue Diagnostics (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Tissue Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Tissue Diagnostics (Non-Small Cell Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Tissue Diagnostics (Non-Small Cell Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Tissue Diagnostics (Other Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Tissue Diagnostics (Other Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Tissue Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Tissue Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Tissue Diagnostics (Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Tissue Diagnostics (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Tissue Diagnostics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Tissue Diagnostics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Tissue Diagnostics (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Tissue Diagnostics (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Tissue Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Tissue Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: North America: Tissue Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: North America: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Tissue Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Asia Pacific: Tissue Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Asia Pacific: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Middle East and Africa: Tissue Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Middle East and Africa: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Latin America: Tissue Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Latin America: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Tissue Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Tissue Diagnostics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Tissue Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Tissue Diagnostics Market Forecast: Breakup by Disease (in Million US$), 2024-2032
  • Table 5: Global: Tissue Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Tissue Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Tissue Diagnostics Market Structure
  • Table 8: Global: Tissue Diagnostics Market: Key Players
目次
Product Code: SR112024A1349

The global tissue diagnostics market size reached US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.

Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.

Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global tissue diagnostics market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product type, technology, disease and end-user.

Breakup by Product Type:

Instruments

Consumables

Breakup by Technology:

Immunohistochemistry

In Situ Hybridization

Digital Pathology and Workflow Management

Special Staining

Breakup by Disease:

Breast Cancer

Gastric Cancer

Lymphoma

Prostate Cancer

Non-Small Cell Lung Cancer

Others

Breakup by End-User:

Hospitals

Research Laboratories

Pharmaceutical Companies

Contract Research Organizations

Others

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etc

Key Questions Answered in This Report

  • 1. How big is the global tissue diagnostics market?
  • 2. What is the expected growth rate of the global tissue diagnostics market during 2024-2032?
  • 3. What are the key factors driving the global tissue diagnostics market?
  • 4. What has been the impact of COVID-19 on the global tissue diagnostics market?
  • 5. What is the breakup of the global tissue diagnostics market based on the product type?
  • 6. What is the breakup of the global tissue diagnostics market based on the technology?
  • 7. What is the breakup of the global tissue diagnostics market based on the disease?
  • 8. What is the breakup of the global tissue diagnostics market based on the end-user?
  • 9. What are the key regions in the global tissue diagnostics market?
  • 10. Who are the key players/companies in the global tissue diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tissue Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Technology
  • 5.6 Market Breakup by Disease
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Immunohistochemistry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 In Situ Hybridization
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Digital Pathology and Workflow Management
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Special Staining
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Breast Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Gastric Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Lymphoma
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prostate Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Non-Small Cell Lung Cancer
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Contract Research Organizations
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

  • 14.1 Price Indicators
  • 14.2 Price Structure
  • 14.3 Margin Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Roche
    • 15.3.2 Danaher
    • 15.3.3 Thermo Fisher Scientific
    • 15.3.4 Abbott
    • 15.3.5 Agilent Technologies
    • 15.3.6 Merck
    • 15.3.7 Sakura Finetek Japan
    • 15.3.8 Abcam
    • 15.3.9 BD
    • 15.3.10 Qiagen
    • 15.3.11 Bio SB
    • 15.3.12 Biogenex
    • 15.3.13 Cell Signaling Technology